Background and Aims
Barrett's esophagus (BE) carries a risk of cancer 30-150 times greater than that for an age-matched population without BE [1] . Five-year-survival rates following the diagnosis of esophageal cancer are less than 15 percent [2] . The annual rate of transformation into esophageal adenocarcinoma (EAC) in patient's with non-dysplastic BE is estimated to be between 0.07% to 0.82% [3, 4] . However, the annual rate of progression from low-grade dysplasia (LGD) to high-grade dysplasia (HGD) or EAC is as high as 6.5% [5] [6] [7] and from HGD to EAC is 12-40% [8-10]. Detecting and treating dysplasia is the only way to prevent cancer developing. Current British Society of Gastroenterology (BSG) guidelines
[11] recommend 2-to-5 yearly surveillance endoscopy with quadrantic, 2cm biopsies. This approach is recommended as dysplasia in Barrett's is often flat, patchy and difficult to detect, with only 13% of lesions appearing as visible nodules [12] . These Seattle protocol biopsies may miss up to 40% of treatable cancers [13] . It is well-recognised that the protocol is poorly adhered to with studies reporting only 51% of patients receiving the appropriate number of biopsies; the longer the length of Barrett's the worse the adherence [14, 15] .
To redress these limitations, a number of approaches have been suggested for visualising the neoplastic areas, enabling targeted-biopsy, including; dye sprays [16, 17] and electronic imaging enhancement, such as tri-modal imaging [18] [19] [20] . Acetic acid (AA) is a weak fatty-acid that, when sprayed on Barrett's mucosa, highlights surface patterns and causes an acetowhitening reaction ( Figure 1 and Video 1) [21] . Dysplastic areas lose the acetowhitening effect faster than nondysplastic areas [22] , highlighting areas for targeted-biopsy ( Figure 2 and Video 2). This process is reversible and causes no damage to tissues. Two large cohort studies have demonstrated the effectiveness of AA in dysplasia detection in high-risk populations [23, 24] , demonstrating sensitivities for dysplasia detection of 90-95% and specificities 75-85%. Further work from the same groups have suggested that the number of biopsies needed to detect neoplasia could be significantly reduced if AA-targeted biopsies were used in place of Seattle protocol biopsies, reducing pathology related costs by 97% [25] . Tholoor et al. [26] reported the use of AA in a surveillance population, demonstrating a six-fold increase in neoplasia detection as compared to Seattle protocol biopsies, with a fifteen-fold decrease in the number of biopsies required. Pohl et al. [24] demonstrated in their large cohort study that the number of AA-targeted biopsies required to yield one diagnosis of dysplasia is 5.2, as compared to 228 mapping biopsies.
The ASGE recently published key performance indicators for targeted-biopsies in Barrett's neoplasia, suggesting cut offs for sensitivity of ≥90%, negative predictive value ≥98% and specificity of 80% [27] . Current published literature is suggestive that AA meets these criteria. However, the accuracy of acetic acid chromoendoscopy (AAC) has only been reported by experts in tertiary centres. Prior to widespread uptake of this technique clinicians will need to be trained to achieve acceptable accuracy, sensitivity and specificity.
This study reports on the development and validation of a training programme for AAC-assisted lesion recognition by means of an online training module, incorporating still-images and dynamic moving videos, as well as an interactive seminar including observed live procedures. Diagnostic performance and inter-observer agreement for each stage of training was assessed.
Methods
This was a prospective, educational evaluation study conducted at a tertiary referral centre for BE between March and April 2015. The study was approved by the National Health Service (NHS)
Research Ethics Committee, reference number REC 15/SC/0085. The primary aim of this study was to develop and validate a training and assessment programme for AAC. The primary endpoints were to determine the construct validity of the image and video-based test (i.e. that the test appropriately differentiates between experts and non-experts) and determine the content validity of the training module for each stage of training.
Module development
A literature review was performed to identify key features of AAC in Barrett's. Based on this a novel AA classification was developed and validated [28] and learning objectives for the training programme identified. To meet these objectives an online training module was developed using the independent endoscopists with experience in Barrett's endoscopy but no prior formal training in AAC-assisted lesion recognition. The group consisted of 5 consultant gastroenterologists, 2 consultant upper GI surgeons and 6 nurse endoscopists (see Table 1 ).
All were required to complete the training module prior to attending the live-interactive workshop held at Queen Alexandra Hospital on 24 th Prior to undertaking the pre-training assessment, participants were asked to fill out a questionnaire regarding their confidence in the use of AAC, the same questionnaire was completed at the end of the training interventions. Along with confidence, participants were asked their views with regard to switching Barrett's surveillance assessments from 4 quadrant biopsies to an AA-targeted technique.
Validation of the assessment test
Prior to use, the content of the assessment test was evaluated to ensure it differentiates between experts and novices in AAC-assisted lesion recognition. Two experts in the use of AA (PB, GLW) not involved in the selection of the images and videos for the test module, completed the test to benchmark expert performance. To evaluate performance of the test for novices in the AAC, 3 independent endoscopists (1 GI-fellow, 2 consultant gastroenterologists) completed the same test module. Neither the experts nor the novices were involved in the subsequent training exercise.
Statistical analysis
To investigate the construct validity of the assessment test, we assumed sensitivity achieved by expert AA users was 90% and non-users 70%, based on the validation exercise for the assessment test (Table 2a&b ). For a chi-squared test using a 5% significance level, with 80% power and a baseline difference of 20%, 59 independent observations would need to be recorded. However, because the data are not truly independent (same images and videos shown to different observers) we assumed that double the number of observations would satisfy the power calculation.
To examine the content validity of the training module a 10% improvement in sensitivity between pre-(70%) and post-training (80%) performance was deemed to be clinically relevant. For a chisquared test with 5% significance level and 80% power, and again assuming the data are not truly independent, at least 291 observations would be required. Again, because the data are not truly independent, we assumed 780 observations for each stage of assessment, from 13 observers, would more than satisfy the power calculation Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV,)
were calculated for each observer (n=13) at each timepoint, using histopathological diagnosis as the reference standard. All analysis was performed using these summary values. Confidence intervals were calculated to illustrate the uncertainty in the estimated values, and, the 2-sided, paired t-test was used to compare between timepoints. A p-value<0.05 was deemed to be significant.
Interobserver agreement for images and videos was assessed using the multi-rater Fleiss kappa () Analyses were performed using the SPSS statistical package, version 22 for Macintosh (IBM corp).
Results

Validation of the assessment module
Outcomes of the assessment module validation exercise are shown in Table 2a&b . These results were used to power the number of participants required for the study. Overall there was a significant difference in performance of experts and novices in both images and video-based assessment. Agreement between experts was extremely high and between novices fair.
RESULTS OF TRAINING
Intervention 1: Online training 13 participants consented to the study. Assessment images and videos were completed prior to the online training module, with outcomes shown in Table 3a&b . Following online training, the assessment tool was completed demonstrating poor baseline performance but a significant improvement in sensitivity and NPV following the online training module.
Intervention 2: Interactive Seminar: dedicated lectures and live case demonstration
Following completion of the interactive training day the assessment tool was repeated (Table 4a&b) showing a statistically significant improvement in sensitivity and NPV for videos and a trend for improvement for images.
Comparison of outcomes: Image vs Video assessments
Assessment by images is no different from assessment by videos (Table 4) , suggesting still-images serve as a reliable surrogate of videos.
Results overall showed improvement in performance after each intervention. The greatest improvement in performance occurred after online training. Additional clinically relevant improvements, in particular for NPV, were seen following the interactive training day. Table 6 a&b shows a subgroup analysis comparing acetic acid users (n=6) those who had performed over 50 acetic acid procedures prior to study enrolment compared to those who had done fewer, acetic acid naïve (n=7).
Subgroup analysis of Experienced (n>50 procedures) Acetic Acid Users versus Non-experienced
Confidence in technique
Endoscopist confidence in the use of the AAC-technique increased throughout training with a mean pre-training confidence level of 2.5 (5-point scale) with a post-training confidence level of 3.9 (p<0.001). Training increased the willingness of endoscopists to switch from a 2cm quadrantic biopsy protocol to an AA-targeted technique with a mean willingness pre-training of 2.6 (5-point scale) rising to 3.8 post-training (p<0.001). Confidence in in-vivo diagnosis for images also improved during training with mean number of diagnoses made with high confidence 41% pre training rising to 63% after the online training module (p<0.001). The same was true for videos with mean number of diagnoses made with high confidence pre-training 47% rising to 67% following the online training module (p<0.001). Following the interactive training day high-confidence responses rose from 63% to 72% for images (p=0.045) and remained at 67% for videos.
Discussion
This study demonstrates the development of a novel training module for AAC-assisted in-vivo diagnosis of Barrett's neoplasia. We have demonstrated the feasibility of training in AAC by a wellvalidated training module. The advantage of the online training platform is that endoscopists can complete training at their own convenience. On average the online module takes 3 hours to complete. Additional clinical benefit was demonstrated from the interactive training day which we believe is integral to achieving competence in AAC-assisted lesion recognition in BE.
Participants included endoscopists from a variety of backgrounds all of whom demonstrated
clinically relevant improvements in accuracy, sensitivity and NPV for the detection of Barrett's neoplasia with AAC. This demonstrates the validity, effectiveness and widespread applicability of this tool. The technique of AAC is very simple and can be performed by any endoscopist but our data shows that lesion recognition after AAC is not that easy and requires training. This is demonstrated by our baseline assessment data which showed poor performance (pre-training) from both very experienced and inexperienced Barrett's endoscopists, justifying the need and role of our training tool.
There were significant improvements in the interobserver agreement following training with substantial agreement achieved by the end of training. This is important as previous studies [29] have demonstrated low interobserver agreement of non-experts without training in AAC. Clearly, with training interobserver agreement improves.
This study demonstrates that the technique of in-vivo diagnosis for Barrett's neoplasia using AA can be taught using images and videos. However, it appears that endoscopists find it harder to diagnose neoplasia from videos as opposed to still-images. This can be explained as static images have been pre-selected to focus on neoplasia, whereas videos focus on the entire Barrett's segment, requiring more complex interpretation. Video performance improves following training. Sensitivity and NPV improved significantly following the interactive seminar but accuracy and specificity decreased. This can be explained by a higher number of false positives making AA safer -reducing the risk of missed neoplasia. At the end of the training exercise the sensitivity was 98% and 99% for images and videos respectively which is well above the ≥90% required by the ASGE PIVI criteria 28 . The same is true for NPV with mean scores of 97% and 98% for images and videos respectively again reaching the ASGE PIVI criteria 28 of ≥98%. We believe that it is high NPV which is most critical, as this suggests that the neoplasia miss-rate is minimal, highlighting the safety of the technique. The recent ASGE position statement [30] supports AAC targeted-biopsy in expert hands but our data shows that those with training can achieve the same thresholds as experts with our image and video-based assessments.
Training modules on lesion recognition and in-vivo diagnosis have traditionally relied on static images. In real-life, assessments are made on dynamic and moving images. Therefore, assessment and training of endoscopists in AAC-assisted lesion recognition, would in theory, be better performed using video-clips, that more closely reflect real-time practice. Our data, however, show no significant difference in performance when endoscopists are assessed using images or videos.
There are some limitations to this study. We don't know whether success in this training module using images and videos, translates to success in real-life cases. We hope to answer this question following the completion of our randomised, crossover, tandem endoscopy study comparing Seattle protocol and AA-targeted biopsy in Barrett's surveillance (The ABBA Study) [31] . Our construct validity data showed that experts in this field had high sensitivity (95-100%) and high NPV (95-100%). At the end of training, even non-expert, AAC naïve endoscopists were able to achieve sensitivity and specificity within expert range. We believe this important finding demonstrates the strength of our training pathway. We are unable to answer the question as to whether performance drops off with time as there were only 2 weeks between completion of the online training module and the interactive seminar. Another limitation is that the images and videos selected did not include low grade dysplasia, endoscopic recognition of low grade dysplasia is challenging but an important entity given the recent evidence for ablation of low grade dysplasia [32] .
This study has a robust design with a well-validated library of images and videos where the performance of the library was validated prior to its use. This study proves the effectiveness of an online training module for AAC and demonstrates the added clinical value of an interactive training day incorporating expert endoscopists and live cases.
Conclusions
Acetic acid chromoendoscopy is a readily available and cheap technology that has the potential to improve Barrett's surveillance and neoplasia yield. This study suggests that the technique can be taught effectively through a simple and easy to implement training module that could be rolled out on a larger scale. We have demonstrated that the tool has good construct and validity and is universally applicable for endoscopists of all backgrounds, but favours those with limited or no acetic acid experience. 
